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1. Introduction 
Early restoration of coronary perfusion is the most important objective in the management 
of ST-segment elevation myocardial infarction (STEMI), and primary percutaneous coronary 
intervention (PCI) is established as the most effective strategy for it. Advances in 
interventional techniques and pharmacological therapy have made it possible to achieve 
Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow in as many as 95% of patients 
undergoing primary PCI. Nevertheless, optimal myocardial perfusion is not achieved in 
approximately 15% of patients despite of successful opening of infarct-related artery. The 
inadequate myocardial perfusion, or “no-reflow” phenomenon, may be caused by 
microvascular damage after myocardial ischemia, distal coronary emboli resulting from 
thrombus, platelets and atheroma, in situ thrombosis, vasospasm, or cell necrosis and 
regional inflammatory responses induced by reperfusion. The no-reflow phenomenon is 
associated with worse functional and clinical outcomes after STEMI. It was linked to larger 
infarction size, lower ejection fraction, ventricular arrhythmias(Aiello et al.,1995), early 
congestive heart failure(Ito et al.,1996), and even cardiac rupture(Morishima et al.,1995). It may 
have an adverse effect on left ventricular (LV) remodeling(Gerber et al.,2000). Therefore, 
detection of no-reflow early after primary `PCI is important for the risk stratification of 
patients with STEMI. Several invasive and non-invasive imaging modalities have been 
developed to detect no-reflow. We had focused on one of these modalities, myocardial 
contrast echocardiography (MCE), and used it in several clinical studies to investigate the 
pathogenesis of the no-reflow. In this article, we investigated the ability of newly developed, 
real-time 3D MCE to assess the microvascular dysfunction in patients with AMI. 
2. Imaging modalities for assessment of the no-reflow phenomenon 
No-reflow can be assessed during PCI with Thrombolysis In Myocardial Infarction (TIMI) 
flow grade(TIMI Study Group,1985), with TIMI-myocardial perfusion grade(van 't Hof et 
al.,1998) (TMPG), or with coronary flow velocity pattern assessed by Doppler 
guidewire(Iwakura et al.,1996). It can be better quantified by noninvasive imaging 
techniques, such as myocardial contrast echocardiography (MCE), cardiac CT, and contrast-
enhanced cardiac magnetic resonance (CMR).  
2.1 CMR and contrast-enhanced CT 
CMR using gadolinium can diagnose the no-reflow as: 1) lack of gadolinium enhancement 
during first pass (microvascular obstruction); and 2) lack of gadolinium enhancement within a 
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necrotic region, identified by late gadolinium hyperenhancement (Albert et al.,2006) 
(Ingkanisorn et al.,2004). There is a good correlation between gadolinium enhancement during 
first pass and TMPG, thus suggesting that these two parameters might reflect the 
microvascular integrity within the infarct zone (Porto et al.,2007). There is a significant 
correlation between area of microvascular obstruction and that of hyperenhancement on CMR 
(Lund et al.,2004). Presence of substantial microvascular obstruction on CMR also predicts LV 
remodeling (Gerber et al.,2000) (Hombach et al.,2005) and major adverse cardiac events 
(Hombach et al.,2005). Contrast enhanced multi-detector CT also delineates infarct zone as 
hyperenhancement area. Transmural hyperenhancement was observed immediately after 
successful PCI, and its area was correlated with non-viable area assessed by dobutamine stress 
echocardiography (Habis et al.,2007). Thus, hyperenhancement observed early after PCI on 
contrast enhanced CT could be associated with the no-reflow phenomenon.  
2.2 Myocardial contrast echocardiography (MCE) 
MCE uses ultrasonic contrast agent containing microbubbles which are strong scatters in an 
ultrasonic field and send compression and rarefaction waves back to the scanner. MCE has 
been proven useful in evaluating patients with AMI receiving reperfusion therapy. Ito et al. 
examined myocardial microvascular perfusion with MCE in patients with AMI, and found 
that some patients showed a lack of contrast enhancement (no-reflow) after successful PCI(Ito 
et al.,1992). Their finding is the first clinical report of the no-reflow phenomenon in patients 
with AMI. They demonstrated patients with substantial no-reflow have poor functional and 
clinical outcomes after AMI (Ito et al.,1996). They performed MCE using intracoronary 
injection of fragile microbubbles through catheter. The no-reflow phenomenon was also 
observed by MCE with intravenous administration of stable microbubbles, which is capable of 
passing through pulmonary circulation and into coronary microcirculation (Porter et al.,1998). 
These studies indicated that no-reflow phenomenon is observed in 25-40% of patients 
receiving successful primary PCI resulting into TIMI-3 flow grade. The substantial myocardial 
contrast defect on MCE predicts poor recovery of contractile function (Ito et al.,1992)(Balcells et 
al.,2003) and is associated with both death and recurrent infarction on the later stage (Dwivedi 
et al.,2007). Multicenter studies have recently demonstrated that the extent of microvascular 
damage, assessed on day 1 after reperfusion therapy in AMI, is the most powerful 
independent predictor of development of LV remodeling (Galiuto et al.,2008). 
Accumulating study results proved the usefulness of MCE as a clinical tool for evaluating 
myocardial perfusion, though no contrast agent is approved for this indication currently. 
MCE has its pros and cons comparing to other imaging modalities such as CMR (Table 1).  
 
 CMR MCE
Contrast Agent Gadomium Microbubbles
Resolution High Spatial Resolution High Temporal Resolution 
Image quality Good in almost all cases Sometimes inappropriate 
Reproducibility Excellent Moderate
Acquisition About 30 minutes Real-time
Image mode 2D/3D 2D
Measurement Area/Volume Area
Operation In MRI lab Bedside / in cath-lab 
Table 1. Characteritics of CMR and MCE 
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MCE is a very easy method not requiring a large apparatus, and it can be performed not 
only in the echo-lab but also in bed side or in the cath-lab. MCE is a suitable imaging 
modality for assessing myocardial perfusion soon after PCI. On the other hand, 
interpretation of MCE depends on the quality of obtained images and it could be difficult to 
obtain reliable images in some cases. Quantification of contrast enhancement on MCE is 
possible but is still difficult and requires complicated techniques. Even the subjective 
evaluation of myocardial perfusion is difficult in some cases because of attenuation, lung 
and rib shadowing, apical bubble distraction by ultrasound. 
2.3 Potential of real-time 3D-MCE 
3D-image reconstruction is the other advantage of CMR over MCE. Precise assessment of 
myocardial perfusion in a whole LV can be achieved by 3D-imaging. 2D-MCE observes 
myocardial opacification only on very limited slices, and assessment of contrast defect 
could be insufficient. Most of myocardial wall thickening is determined by contractile 
function of the subendocardial layer (Hashimoto et al.,2003), and recovery of contractility 
after AMI mostly depends on the viability of the subendocardial layer (Garot et al.,2000). 
Ischemic myocardial injury progress from endocardial- to epicardial layers (wavefront 
phenomenon), and subendocardium is the most vulnerable layer to ischemic insults 
(Grattan et al.,1986). Assessment of subendocardial perfusion is important for prediction 
of contratile function after AMI. 2D-MCE has only limited ability to visualize 
subendocardial perfusion.  
3D- echocardiography visualizes the whole LV, and it is superior to 2D-echocardiography in 
assessment of regional wall motion abnormalities (Corsi et al.,2005). It also visualizes 
endocardial surface structure within a beating heart (Inoue et al.,2006). In the next chapter, 
we investigated whether real-time 3D-MCE could assess subendocardial perfusion in 
patients with AMI undergoing primary PCI , and compared its perfusion patterns to those 
obtained with 2D-MCE (Iwakura et al.,2007). We also compared the ability of these two 
modalities to assess infarct size and to predict functional recovery. 
3. Assessment of subendocardial perfusion by real-time 3D-MCE 
3.1 Study population and protocol 
Between October 2004 and December 2005, consecutive 68 patients with AMI underwent 
primary PCI within 24 hours after symptom onset, and subsequently underwent 
intracoronary 2D- and 3D-MCE study. The diagnosis of AMI was based on the chest pain 
prolonged ≥ 30 minutes, ST segment elevation of ≥ 2 mm in at least two contiguous 
electrocardiograph leads, and greater than 3 fold increase in serum creatine kinase (CK) 
levels. Seven patients were excluded because of poor echocardiograph images, including 2 
patients in whom 2D-MCE was adequate but 3D-MCE was suboptimal. We excluded 14 
patients who did not undergo follow-up left ventriculography (LVG) study. Therefore, the 
final study population consisted of 47 patients.  
After the admission, we performed echocardiography examination with SONOS 7500 
(Philips Medical Systems), and defined the risk area as myocardial segments showing 
dyskinesia, akinesia or severe hypokinesia. After aspirin (243 mg) and intravenous heparin 
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(100 U/kg) administration, we performed coronary angiography (CAG) using the right 
femoral approach. We determined the culprit lesion and performed primary PCI to achieve 
the residual diameter stenosis < 25 %. After the PCI procedure, we assessed TMPG on CAG 
from the view chosen to minimize superimposition of non-infarcted territories(Gibson et 
al.,2000).  
A mean of 15 minutes after the last PCI procedure, we performed 2D-MCE with SONOS 
7500 using a S4 transducer. We made microbubbles of a mean size of 12 µm by sonicating 
iodinated contrast medium, Ioxagate (Hexabrix-320, Tanabe), using an ultrasonic 
homogenizer with a sterilized tip (Figure 1). We injected 2 mL of sonicated medium into the 
right coronary artery in patients with inferior wall AMI and into the left coronary artery in 
those with anterior or posterior wall AMI. We recorded 2D-echocardiogram from the apical 
two- or four-chamber view. Then, we performed real time 3D-MCE using Live 3D system 
without ECG gating. We observed 3D images from apical 2- or 4-chamber view with an X4 
matrix array transducer on second harmonic mode. We adjusted time-gain compensation 
and lateral gain control carefully to obtain clear view of endocardial surface. Then, we 
injected microbubbles into culprit coronary artery again, and recorded a 3D-MCE image for 
20 heartbeats. All MCE images were digitally stored for the further analysis. 
 
Fig. 1. Sonification of contrast medium to make microbubbles for MCE 
We performed LVG in 42 patients (89.4%) following MCE study, and measured left 
ventricular end-diastolic and end-systolic volume index (LVEDVI and LVESVI, mL/m2) and 
LV ejection fraction (LVEF, %) by the biapical Simpson’s rule. Regional wall motion (RWM, 
SD/chord) within the culprit artery territory was analyzed using the centerline method. 
Follow-up coronary angiography and LVG were performed in all patients at a mean of 
4.6±2.7 months later.  
An experienced echocardiographer analyzed 2D-MCE images to determine myocardial 
perfusion within the risk area. We used the apical long-axis view or apical 4-chamber view 
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for the patients with anterior wall AMI and posterior wall AMI and the apical 2-chamber 
view for the patients with inferior wall AMI. We divided LV wall into myocardial segments 
based on 16-segment model endorsed by American Society of Echocardiography(Cerqueira 
et al.,2002), and scored myocardial opacification in each segment as 1 (homogenous 
opacification), 0.5 (patchy opacification or opacification only in epicardium), or 0 (no 
opacification)(Ragosta et al.,1994). We calculated the averaged contrast score by dividing the 
sum of contrast scores in the segments within risk area by the number of these segments. We 
graded myocardial perfusion in each patient as good- (the averaged score = 1), poor- (0.5 ≤ 
score <1.0) and no-reflow (score <0.5).  
A sonographer blinded to 2D-MCE data assessed subendocardial contrast opacification on 
end-systolic 3D-MCE images. For assessing the risk area and myocardial perfusion, we used 
the echo windows to include the whole risk area within 3D echocardiograph image. We 
observed myocardial opacification from LV cavity side. The “shade” mode was activated to 
reduce the effect of opacification from the epicardial layers. If necessary, some parts of the 
LV were cropped to obtain clear image of endocardial surface (Figure 2). Risk area was 
defined as myocardium showing no contraction of endocardial surface. We divided whole 
LV into myocardial segments corresponding to those of 16-segment model in 2D-
echocardiogram(Kapetanakis et al.,2005), and scored endocardial opacification within each 
segment as 1 (enhancement as good as that within nearby normal segment), 0.5 
(enhancement was observed but not as strong as that within the normal area), or 0 (no clear 
enhancement). We calculated the averaged endocardial contrast score in the segments 
within the risk area. We graded myocardial opacification in endocardium (MOE) into 3 
groups; good- (the averaged score = 1), poor- (0.5 ≤ score <1.0) and no-MOE (score <0.5). 
 
Fig. 2. Cropping of 3D-MCE images to reveal endocardial surface 
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All data are expressed as mean ± SD. We made comparisons by one-way ANOVA for 
continuous variables, and significance of difference was calculated with Tukey’s HSD test 
for factor analysis. Categorical variables were compared with the Fisher’s exact test. The 
differences in the changes of RWM from the initial- to the follow-up LVG study among the 
groups were analyzed with multivariate analysis of variance (MANOVA). Differences were 
considered significant at P < 0.05 (two-sided).  
3.2 Patient characteristics 
The mean age of the 47 study patients was 61±11 years (range 40 to 81 years), and 38 
patients (80.9%) were male. The culprit artery was the left anterior descending artery in 28 
patients, the left circumflex artery in 6 patients and the right coronary artery in 13 patients. 
Multivessel disease was observed in 12 patients. The mean time from the symptom onset to 
coronary reperfusion was 12.3 ± 14.2 hours. The peak CK and CK-MB level was 3069±2490 
IU/L and 235±185 IU/L, respectively.  
3.3 Representative cases of 3D-MCE 
Figures 3 shows 2D- and 3D-MCE images in a patient with inferior wall AMI. 2D-MCE 
(upper left) showed good-reflow within the risk area (between arrows). On 3D-
echocardiograph before injection, endocardial surface of area at risk was revealed through 
cropping (lower left). After microbubble injection, contrast enhancement was observed 
within the risk area, and we judged this case as good-MOE. Peak CK and CK-MB of this 
case were 1977 IU/L and 118 IU/L, respectively.  
 
Fig. 3. A representative case showing good-reflow on 2D-MCE (a) and good-MOE on 3D-
MCE (c).  
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Figure 4 showed MCE images in a patient with posterior wall AMI. 2D-MCE (upper left) 
showed good-reflow within the risk area (between arrows). 3D-MCE (right) showed almost 
no endocardial contrast enhancement (no-MOE) within the risk area (between arrows). A 
good contrast enhancement was observed in the normal myocardium around the risk are 
(Compare it to the 3D-image before contrast injection, on lower left). Peak CK and CK-MB of 
this case were 4758 IU/L and 414 IU/L, respectively.  
 
 
 
 
 
 
 
 
Fig. 4. A case with posterior AMI showing good-reflow on 2D-MCE (a) but no-MOE on 3D-
MCE (c). 
Figure 5 showed interesting images obtained in other case with anterior wall AMI. Good 
opacification was observed on endocardial surface of septum on 3D-MCE at 790msec after 
injection of microbubbles (b). Then, a jet of contrast medium was observed to flow out 
directly from the apical myocardium (arrow) at 2220 msec (c) and 2990 msec (d) after 
injection ( (e) and (f) are zoomed images of (c) and (d) ). These images demonstrated that 
endocardial hemorrhage occurred immediately after AMI. Possibly rupture of 
subendocardial hematoma occurred in this case (Iwakura, 2011).  
www.intechopen.com
 
Echocardiography – New Techniques 
 
134 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Endocardial hemorrhage observed immediately after primary PCI. 
3.4 Assessment of endocardial perfusion with 3D-MCE.  
2D-MCE showed good-reflow in 31 out of 47 study patients (66.0%), poor-reflow in 9 
patients (19.1%) and no-reflow in 7 patients (14.9%). Patient characteristics of each group 
were illustrated in Table 2. The incidence of anterior wall AMI was significantly higher in 
the no- and poor-reflow than the good-reflow (p=.01). The additional ST elevation after 
reperfusion was more frequently observed in the no-reflow (p=.04). There were significant 
differences in the incidence of the multivessel disease (p=.02) and the collateral grade 
(p=.03) among three subsets (Table 2). 
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Table 2. Clinical parameters of the study patients. 
Good-MOE was observed on 3D-MCE only in 17 patients (36.2%). Poor-MOE was observed in 
16 patients (34.0%) and no-MOE in 14 patients (29.8%). Among the 31 patients with good-
reflow on 2D-MCE, only 14 patients (45.2 %) showed good-MOE, and 4 patients (12.9%) 
showed no-MOE. In contrast, all 7 patients with no-reflow on 2D-MCE showed no-MOE on 
3D-MCE (Table 3).  
 
 3D-MCE  
2D-MCE Good-MOE, n Poor-MOE, n No-MOE, n Total, n 
Good-reflow, n 14 13 3 31 
Poor-reflow, n 3 3 3 9 
No-reflow, n 0 0 7 7 
Total, n 17 16 14 47 
Table 3. Distribution of myocardial perfusion grade on 2D- and 3D-MCE 
Among the 31 patients with good-reflow, only 19 patients (61.3%) showed TMPG-3, and 6 
patients showed TMPG-0/1 on CAG after PCI. On the other hand, 16 out of 17 patients 
(94.1%) with good-MOE showed TMPG-3. 
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3.5 Prediction of infarct size with 2D- and 3D-MCE 
Among the 3 groups classified with 2D-MCE, the no-reflow had the highest peak-CK value 
(5240±3040 IU/L), followed by the poor-reflow (3195±2209 IU/L) and the good-reflow 
(2516±2186 IU/L). The differences in peak CK among three subsets were significant (p=.03), 
and the no-reflow had significantly higher peak CK than the good-reflow. However, the 
differences in peak CK between the poor-reflow and the good- or the no-reflow did not 
reach statistical significance (Figure 6). There were no significant differences in CK-MB 
values among the three subsets (p=0.16). 
 
Fig. 6. Peak CK/CK-MB and myocardial perfusion grade on 2D/3D-MCE 
The no-MOE on 3D-MCE also had the highest peak CK value (5583±2345 IU/L), followed by 
the poor-MOE (2796±1700 IU/L) and by the good –MOE (1166±1080 IU/L). The differences 
in peak CK were significant not only among 3 groups (p<.0001) but also in each pair of 
groups (Figure 6). Moreover, there were significant differences in CK-MB among 3 groups 
(p<.0001). The good-MOE had significantly lower CK-MB then the poor- (p=.01) or the no-
MOE (p<.0001) (Figure 6). These results indicated that myocardial perfusion grade by 3D-
MCE predicted infarct size more distinctively than that by 2D-MCE does.  
3.6 Prediction of LV functional and morphological outcomes with 2D- and 3D-MCE 
At baseline study, there was no significant difference in RWM among 3 groups based on 
2D-MCE. The good-MOE had the highest RWM among 3 groups based on 3D-MCE at 
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baseline study (good-/poor-/no-MOE = -2.28±0.91/-3.03±0.67/-2.99±0.71, p=0.02). A 
mean of 4.6±2.7 months later, RWM of the no-reflow (-2.84±0.83) was lower than that of 
the good-reflow (-1.37±1.11, p=.004). However, RWM was not statistically different 
between the poor-reflow (-1.73±0.71) and the good-reflow or the no-reflow (Figure 7). On 
the other hand, there were significant differences in RWM in each pair of the 3 groups 
defined by 3D-MCE (Figure 7).  
 
 
 
 
Fig. 7. RWM on the chronic stage and myocardial perfusion grade on 2D/3D-MCE 
Among the 42 patients in whom initial ventriculography study was performed, the 
improvement of RWM from baseline to follow-up study was the highest in the good-MOE, 
followed by the poor-MOE and the no-MOE (1.59±0.98 vs. 1.19±0.71 vs. 0.31±0.84, p=.001). 
Although RWM improvement was also the highest in the good-reflow, but it showed 
significant overlap among 3 groups, and no significant differences were observed among 
them (p=0.10). These results implied that myocardial perfusion pattern assessed with 3D-
MCE predicts the functional recovery more definitively than that with 2D-MCE. 
There were no differences in LVEDVI and LVESVI at baseline study among 3 groups based on 
2D-MCE, and there were no significant differences in LVEDVI and LVESVI among 3 groups at 
(a)
(b)
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follow-up study. The no-reflow had significantly lower ejection fraction than the good-reflow 
at baseline study. At the follow-up study, the good-reflow showed higher LVEF than the no-
reflow, but LVEF of the poor-reflow showed significant overlap with those of other two 
subsets (Figure 8). At baseline, LVEDVI was comparable among 3 groups defined by 3D-MCE. 
The good-MOE had smaller LVESVI than the no-MOE and better LVEF than other two groups 
on initial LVG. At the follow-up study, the no-MOE had larger LVEDVI than the good-MOE, 
and larger LVESVI and LVEF fraction than two other groups (Figure 8).  
 
Fig. 8. LV volume index and LVEF on the chronic stage 
4. 3D-MCE as a novel method for assessment of subendocardial perfusion 
The present study demonstrated that subendocardial perfusion after coronary recanalization 
was well visualized with 3D-MCE in patients with AMI. Assessment of subendocardial 
perfusion with 3D-MCE predicted infarct size and discriminated patients with poor functional 
outcome more precisely than 2D-MCE. We used intracoronary injection of microbubbles for 
3D-MCE rather than intravenous injection because intravenous injection of contrast agent 
would make LV filled with microbubbles, which make endocardial surface invisible. 
4.1 Comparison between 2D- and 3D-MCE for detection of the no-reflow 
While the no-reflow assessed by 2D-MCE is associated with poor functional recovery after 
AMI, the microvascular integrity does not always go along with functional recovery on the 
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chronic stage(Galiuto et al.,1998). TMPG-3 on coronary angiogram is generally achieved only 
in less than 30% of the patients with AMI after primary PCI(Gibson et al.,2000)(Costantini et 
al.,2004), while good reflow is observed on 2D-MCE in about 70% of the patients(Ito et 
al.,1992)(Galiuto et al.,1998)(Porter et al.,1998). TMPG grade was far better correlated with 
MOE on 3D-MCE than with perfusion pattern on 2D-MCE in the present study. Thus, 2D-
MCE might overestimate myocardial reperfusion and predict functional recovery 
excessively(Bolognese et al.,1996).  
Myocardial perfusion patterns assessed by 3D-MCE were not necessarily coincident with 
those with 2D-MCE. The frequency of good-MOE on 3D-MCE was significantly lower than 
that of good reflow on 2D-MCE (36.2% vs. 66.0%) in the present study. Although 2D-MCE 
might detect subendocardial perfusion defect in some cases(Ragosta et al.,1994), it basically 
could not well assess transmural differences in myocardial perfusion(Kaul et al.,1992). 3D-
MCE observes contrast opacification on the endocardial surface directly from the view point 
of LV cavity, and could assess subendocardial perfusion more precisely than 2D-MCE. 
Nevertheless, direct observation of subendocardial opacification has some limitations for 
precise subendocardial perfusion. Contrast signal from the mid-layers might contaminate 
the subendocardial opacification, even with adjustment of recording conditions to reduce 
such interference. We used sonicated contrast medium for intracoronary MCE, which 
contains various sized microbubbles(Ito et al.,1992). Large bubbles work as scatters rather 
than reflectors of ultrasound, and ultrasound scatter would produce false ultrasound signals 
in the neighboring myocardium. This interference has the potential for inhibiting the 
discrimination between endocardium and epicardium on 3D-MCE(Kaul et al.,1992). 
While 2D-MCE observed myocardial perfusion only in a slice of the risk area, 3D-MCE 
observed spatial distribution of perfusion more widely. If the echo-plane on 2D-MCE is not 
placed at the center area of the infarct zone, we would observe myocardial perfusion at the 
marginal zone. Microvascular injury in the peripheral zone is not as severe as in the center 
area, and myocardial perfusion could be overestimated. The 3D-MCE image in Figure 4 
showed high contrast enhancement area around the central risk area. This could be 
hyperemic response occurring at the marginal area. Presence of hyperemia might make 2D-
MCE overestimate myocardial perfusion. 
4.2 Limitation of the study 
In the present study, we used real-time 3D echocardiography (Live-3D) instead of full-
volume imaging. Real-time 3D acquisition is limited to an angle of about 30° - 50° degrees, 
and provides only a partial view of LV. To cover the complete LV, acquisition of wide-angle 
(‘full-volume’) volumetric data sets using ECG gating is required. 3D-contrast 
echocardiography, using intravenous contrast agents, assesses LV volumes more precisely 
than 2D-contrast echocardiography or 3D-echocardiography in patients with a history of 
myocardial infarction(Jenkins et al.,2009). LV volumes measured with 3D-contrast 
echocardiography is compatible with those measured on CMR. However, 3D-contrast 
echocardiography was used to delineate endocardial border clearly (LV opacification), and 
myocardial perfusion was not assessed in these studies. Full-volume 3D-MCE will not only 
assess myocardial perfusion within a complete LV, but will be able to measure myocardial 
volume showing microvascular dysfunction. At the time of the present study, the image-
analysis software for SONOS 7500 was not suitable for observation of contrast enhancement 
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in a full-volume image, let alone measurement of the volume of microvascular dysfunction. 
New software should be developed to analyze a full-volume 3D-MCE image quantitatively. 
Despite of the limitation described above, real-time 3D-MCE has some advantages over full-
volume imaging, including direct and easy observation of changes in endocardial structures. 
In one of the present study patients, we observed eruption of contrast medium from 
endocardial surface immediately after intracoronary injection of microbubbles. We 
considered this phenomenon as indicating rupture of subendocardial hematoma. In an 
experimental model, intramural hemorrhage is not observed early after coronary 
reperfusion on intracoronary 2D-MCE (Shishido et al.,1997). The contrast defect spread 
significantly with time after reperfusion in the cases developing intramural hemorrhage, but 
enhancement immediately after reperfusion was compatible between those with and 
without hemorrhage (Shishido et al.,1997). 2D-MCE might fail to detect small hemorrhage 
limited to the subendocardial layer, while 3D-MCE could detect it by direct observation of 
endocardial surface. Thus, real time 3D-MCE is a promising method not only to observe on 
endocardial perfusion but also to observe pathological events occurring endocardial surface. 
The present real time 3D-MCE technique has other limitations. The spatial resolution of 3D-
echocardiograhy is still inferior to that of 2D-echocardiography, which might lead to the 
poorer 3D-MCE image quality. We evaluated perfusion pattern and MOE only visually, 
because the present system does not have the objective method to measure myocardial 
opacification on 3D-images. The quantitative measures using replenishment curves which is 
available in 2D-MCE (Wei et al.,1998) still could not be performed in 3D-MCE. We hope that 
the technical progress would soon resolve these technical issues. 
5. Conclusion 
Newly developed, real time 3D-MCE was a feasible method to assess endocardial perfusion 
in patients with AMI. 3D-MCE assessed infarct size and predicted functional outcomes after 
AMI better than 2D-MCE did. It also observed endocardial hemorrhage occurred after PCI 
in one of the study patients. Thus, 3D-MCE is a promising method for assessment of 
microvascular function and of endocardial structural changes immediately after primary 
PCI for AMI. 
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